Company Overview
Caring Brands, Inc. operates as a wellness consumer products company that provides over-the-counter and cosmetic consumer products designed for specific dermatological and cosmetic needs. The entity functions within the broader Healthcare sector, specifically categorized under the Drug Manufacturers - Specialty & Generic industry, which implies a focus on niche therapeutic applications rather than broad-market pharmaceuticals. The company's operational scale is defined by a market capitalization of $18.27M, an annual revenue of $4,493, and an employee count of 4. These specific financial metrics indicate that the organization functions as a micro-cap entity with extremely limited revenue relative to its valuation, suggesting a business model that relies on high-margin, low-volume transactions or significant non-operating assets to justify its market price.
Financial Health
The company reported a revenue of $4,493 for the trailing twelve months, yet it recorded a net income of $-3,083,402 and an EBITDA of $-1,795,663, revealing a severe structural gap where operating expenses and losses vastly exceed all generated sales. Despite the substantial net loss, the company reports a positive free cash flow of $509,491, which indicates a degree of financial flexibility potentially derived from non-cash accounting adjustments or specific cash flow timing differences rather than core operational profitability. The company's profitability metrics are distorted by extreme negative margins, including a gross margin of -6.9%, an operating margin of -135064.2%, and a profit margin of 0.0%, all of which signal that the business is currently burning capital without generating sustainable earnings from its primary operations. On the balance sheet, the company holds $16,123 in cash against $131,268 in debt, resulting in a debt-to-equity ratio of 5.05, which characterizes the entity as highly leveraged with a liability structure that significantly outweighs its equity base. Liquidity is critically constrained, evidenced by a current ratio of 0.08, indicating that the company possesses less than one-tenth of the current assets necessary to cover its current liabilities without external financing. Finally, the return metrics reflect this financial distress, with a return on equity of -251.4% and a return on assets of -83.5%, revealing that management has failed to generate any positive returns on the capital invested in the firm.
Valuation Assessment
The valuation multiples for Caring Brands, Inc. are technically unavailable or non-standard due to its financial status, as the trailing P/E and forward P/E are both listed as N/A, implying that the absence of earnings prevents the calculation of a traditional earnings multiple and suggests no clear expected earnings trajectory based on current performance. The company trades at a price-to-book ratio of 6.56, a figure that indicates a significant market premium over its book value despite the company's negative net income and lack of retained earnings accumulation. Alternative valuation metrics further highlight the disconnect between market price and operational reality, with a price-to-sales ratio of 4067.17 and an EV/EBITDA of -9.55, suggesting that the market is pricing the stock based on speculative factors rather than current sales or earnings power. The stock has exhibited volatility within a range defined by a 52-week high of $1.65 and a 52-week low of $0.71, meaning the current price sits at a level that reflects the extreme uncertainty surrounding the asset. The beta is listed as N/A, which means volatility relative to the broader market cannot be quantified using standard historical data, leaving investors without a benchmark to gauge systematic risk.
Growth & Income
Growth metrics for the company are unavailable, as the revenue growth and earnings growth rates are both listed as N/A, indicating that there is insufficient historical data to determine whether earnings are growing faster or slower than revenue. Because the company does not pay dividends, with a dividend yield of N/A and a payout ratio of N/A, the firm does not distribute income to shareholders but instead reinvests its limited earnings or cash reserves into growth initiatives. This reinvestment strategy is necessary given that the company generates a net loss, meaning any retained capital is being used to fund operations or reduce the substantial debt load rather than rewarding investors. The overall growth and income profile is characterized by a complete absence of historical growth data and a lack of dividend income, presenting a speculative asset class that relies entirely on future operational turnaround rather than current cash generation or shareholder distributions.